Tardyferon

Tardyferon is an oral iron supplementation medication developed by Pierre Fabre Médicament for the treatment and prevention of iron deficiency anemia. The active ingredient is ferrous sulfate, which is provided in a prolonged-release (sustained-release) formulation to ensure gradual iron release in the gastrointestinal tract, thereby improving gastrointestinal tolerability and optimizing absorption. It is primarily indicated for iron deficiency states, including those associated with pregnancy, lactation, and inadequate dietary intake or impaired absorption. By providing elemental iron, Tardyferon facilitates the synthesis of hemoglobin, which is essential for oxygen transport in the blood.

Brand names

Tardyferon

Other names

ferrous sulfateferrous sulphateferrous sulfate heptahydrate